Anbio Biotechnology
Designs and distributes diagnostic products for laboratory, point-of-care, and home-use settings.
$7.55
After-hours close−0.03 (−0.33%)
At close$7.58(−2.63%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 0.11%Insiders —
Shares outstanding 43.89M · Float 39.69M · 90.4% free float
Institutions13F, as of Mar 31, 2026
8 holders · 50.2K shares · 3 new positions · 6 increased · 0 reduced · 0 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 25.8K | 0.06% | 0 | May 15, 2026 |
| BNP Paribas Arbitrage, SNC | 10.4K | 0.02% | +9.4K | May 12, 2026 |
| Morgan Stanley | 7.3K | 0.02% | +7.3K | May 15, 2026 |
| UBS Group AG | 6.3K | 0.01% | +3.5K | May 5, 2026 |
| Eversource Wealth Advisors, LLC | 266 | 0.00% | +266new | May 18, 2026 |
| Wells Fargo & Company/MN | 100 | 0.00% | 0 | Jul 8, 2026 |
| Bare Financial Services, Inc | 15 | 0.00% | +15new | May 14, 2026 |
| Ronald Blue Trust, Inc. | 5 | 0.00% | +5new | Apr 20, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.